Evolus Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:EVL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
06 Sep 24	Sell€44,196	Sandra Beaver	Individual	3,276	€13.49
30 Aug 24	Sell€80,692	Tomoko Yamagishi-Dressler	Individual	5,631	€14.33
04 Jun 24	Sell€1,640,126	David Moatazedi	Individual	140,214	€11.70
03 Jun 24	Sell€89,291	Vikram Malik	Individual	7,500	€11.91
14 May 24	Sell€121,105	David Gill	Individual	10,361	€11.76
13 May 24	Sell€335,404	Vikram Malik	Individual	28,000	€11.98
10 May 24	Sell€28,611	Sandra Beaver	Individual	2,423	€11.81
10 May 24	Sell€40,632	Rui Avelar	Individual	3,441	€11.81
10 May 24	Sell€189,532	David Moatazedi	Individual	16,051	€11.81
27 Mar 24	Sell€79,879	David Moatazedi	Individual	6,236	€12.81
19 Mar 24	Sell€1,238,112	David Moatazedi	Individual	96,566	€12.82
19 Mar 24	Sell€72,723	Sandra Beaver	Individual	5,672	€12.82
19 Mar 24	Sell€353,909	Rui Avelar	Individual	27,603	€12.82
22 Feb 24	Sell€93,193	David Moatazedi	Individual	7,706	€12.09
08 Dec 23	Sell€764,910	David Moatazedi	Individual	82,648	€9.38

Insider Trading Volume

Insider Buying: EVL insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of EVL?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,248,032	1.97%
Public Companies	3,136,869	4.95%
Private Companies	3,381,326	5.34%
General Public	4,791,288	7.57%
VC/PE Firms	5,356,622	8.46%
Institutions	45,407,356	71.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.8%.

Top Shareholders

Top 25 shareholders own 73% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.46%	Perceptive Advisors LLC	5,356,622	€64.7m	-6.9%	1.46%
7.66%	Tang Capital Management, LLC	4,847,399	€58.6m	0%	4.45%
6.68%	BlackRock, Inc.	4,230,149	€51.1m	5.54%	no data
5.34%	Medytox Korea Co. Ltd	3,381,326	€40.9m	0%	no data
5.05%	The Vanguard Group, Inc.	3,195,331	€38.6m	7.04%	no data
4.95%	Daewoong Pharmaceutical Co., Ltd	3,136,869	€37.9m	0%	no data
4.46%	Nantahala Capital Management, LLC	2,824,849	€34.1m	-2.95%	2.55%
3.46%	Caligan Partners, LP	2,193,488	€26.5m	1.19%	8.3%
2.16%	Stonepine Capital Management LLC	1,369,821	€16.6m	-17.4%	5.79%
2.02%	State Street Global Advisors, Inc.	1,277,841	€15.4m	-4.57%	no data
1.91%	Geode Capital Management, LLC	1,210,621	€14.6m	0.92%	no data
1.85%	Great Point Partners, LLC	1,170,000	€14.1m	-52.3%	5.26%
1.64%	Soleus Capital Management, L.P.	1,037,680	€12.5m	-9.92%	0.94%
1.63%	Millennium Management LLC	1,029,670	€12.4m	14.5%	0.01%
1.6%	Schroder Investment Management North America Inc.	1,014,960	€12.3m	3.82%	0.04%
1.57%	Lord, Abbett & Co. LLC	995,449	€12.0m	23.4%	0.04%
1.55%	Boothbay Fund Management, LLC	983,702	€11.9m	-1.29%	0.39%
1.55%	Morgan Stanley, Investment Banking and Brokerage Investments	979,326	€11.8m	-31.7%	no data
1.53%	D. E. Shaw & Co., L.P.	970,270	€11.7m	11.4%	0.02%
1.51%	Assenagon Asset Management S.A.	955,555	€11.5m	0.89%	0.02%
1.43%	Rice Hall James & Associates, LLC	904,900	€10.9m	6.3%	0.59%
1.42%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	897,106	€10.8m	51%	no data
1.34%	Soros Fund Management LLC	850,000	€10.3m	0%	0.27%
1.19%	UBS Asset Management AG	753,532	€9.1m	-2.06%	no data
1.04%	AWH Capital, L.P.	657,500	€7.9m	-2.59%	7.18%